Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

China flag China · Delayed Price · Currency is CNY
1.950
+0.010 (0.51%)
Jun 4, 2025, 10:44 AM CST
5.41%
Market Cap 27.03B
Revenue (ttm) 5.29B
Net Income (ttm) 9.61M
Shares Out 13.86B
EPS (ttm) 0.00
PE Ratio 2,813.71
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 58,342,196
Average Volume 126,857,880
Open 1.960
Previous Close 1.950
Day's Range 1.950 - 1.960
52-Week Range 1.680 - 2.950
Beta 0.72
RSI 42.68
Earnings Date Aug 21, 2025

About Kangmei Pharmaceutical

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceuti... [Read more]

Sector Healthcare
Founded 1997
Employees 4,233
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600518
Full Company Profile

Financial Performance

In 2024, Kangmei Pharmaceutical's revenue was 5.19 billion, an increase of 6.47% compared to the previous year's 4.87 billion. Earnings were 8.57 million, a decrease of -91.64%.

Financial Statements

News

There is no news available yet.